Lies, damned lies and statistics. The art of the CGM accuracy study.
How do you compare two different CGMs? It seems like a stupid question. It’s obvious. You look at the Mean Absolute Relative Difference (MARD) of […]
Abbott
Abbott Freestyle Libre 3 – here already?
It was only a little over a week ago that Abbott released their Libre Sense, offering up CGM for athletes without a medical approval, with […]
High temperatures, extreme conditions and glucose sensors… an n=1 observation
As many of us do going in to the new year, I made a decision to be more active, eat more healthily, etc. The usual […]
Death or profit: Flash, CGM and patient-centricity
As many people with T1D in the UK will know, there has been an ongoing dialogue between NHS England and the DVLA with respect to […]
Happy World Diabetes Day from NHS England – #FreestyleLibre for all?
World Diabetes Day 2018. The day that NHS England had enough. The announcement If you hadn’t seen it, NHS England issued a press release early […]
#FreeStyleLibre2 – further thoughts
The big question that remains for many more technical users in relation to the FreeStyle Libre 2 is whether it is transmitting glucose data or […]
The real cost of Time in Range – what it takes to replace Hba1C #ATTD2018
Anyone watching the Twitter feed for the Advanced Technologies and Treatments for Diabetes 2018 conference can’t fail to have noticed that, once again, the answer […]
Roll up, roll up. The #Freestyle Libre postcode lottery has started. You gotta be in it to win it….
Earlier today, the first NHS England CCG response to the Libre appeared on Twitter, from the East of England Priorities Advisory Committee. Looking to the […]
Abbott’s Freestyle Libre. FDA approved at last. What does this mean?
Two days ago, Abbott announced they had received FDA approval for the Freestyle Libre, some 3 years after European approval. That feels like a long […]